Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones.

Leventhal AM, Japuntich SJ, Piper ME, Jorenby DE, Schlam TR, Baker TB.

Psychol Addict Behav. 2012 Dec;26(4):838-49. doi: 10.1037/a0028449. Epub 2012 May 28.

2.

Smoker characteristics and smoking-cessation milestones.

Japuntich SJ, Leventhal AM, Piper ME, Bolt DM, Roberts LJ, Fiore MC, Baker TB.

Am J Prev Med. 2011 Mar;40(3):286-94. doi: 10.1016/j.amepre.2010.11.016.

3.

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.

Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M.

J Clin Psychopharmacol. 2008 Dec;28(6):660-6. doi: 10.1097/JCP.0b013e31818ad7d6.

4.

Using ecological measures of smoking trigger exposure to predict smoking cessation milestones.

Minami H, Tran LT, McCarthy DE.

Psychol Addict Behav. 2015 Mar;29(1):122-8. doi: 10.1037/adb0000017. Epub 2014 Aug 18.

5.

The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.

Japuntich SJ, Piper ME, Leventhal AM, Bolt DM, Baker TB.

J Consult Clin Psychol. 2011 Feb;79(1):34-42. doi: 10.1037/a0022154.

6.

Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.

Saxon AJ, Baer JS, Davis TM, Sloan KL, Malte CA, Fitzgibbons K, Kivlahan DR.

Nicotine Tob Res. 2003 Aug;5(4):589-96.

PMID:
12959797
7.

The alternative five-factor model of personality, nicotine dependence and relapse after treatment for smoking cessation.

Nieva G, Valero S, Bruguera E, Andión Ó, Trasovares MV, Gual A, Casas M.

Addict Behav. 2011 Oct;36(10):965-71. doi: 10.1016/j.addbeh.2011.05.008. Epub 2011 May 30.

PMID:
21704460
8.

Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation.

Piper ME, Smith SS, Schlam TR, Fleming MF, Bittrich AA, Brown JL, Leitzke CJ, Zehner ME, Fiore MC, Baker TB.

J Consult Clin Psychol. 2010 Feb;78(1):13-23. doi: 10.1037/a0018065.

9.

Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.

Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB.

Addiction. 2011 Feb;106(2):418-27. doi: 10.1111/j.1360-0443.2010.03173.x. Epub 2010 Oct 25.

10.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
11.

Outcomes from an outpatient smoking-cessation clinic.

Roth MT, Andrus MR, Westman EC.

Pharmacotherapy. 2005 Feb;25(2):279-88.

PMID:
15767242
12.

Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.

Cox LS, Faseru B, Mayo MS, Krebill R, Snow TS, Bronars CA, Nollen NL, Choi WS, Okuyemi KS, Salzman GA, Benowitz NL, Tyndale RF, Ahluwalia JS.

Trials. 2011 Jan 25;12:22. doi: 10.1186/1745-6215-12-22.

13.

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.

Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):111-8. doi: 10.1016/j.drugalcdep.2011.03.005. Epub 2011 Apr 19.

14.

Anxiety and depressive symptoms and affective patterns of tobacco withdrawal.

Leventhal AM, Ameringer KJ, Osborn E, Zvolensky MJ, Langdon KJ.

Drug Alcohol Depend. 2013 Dec 1;133(2):324-9. doi: 10.1016/j.drugalcdep.2013.06.015. Epub 2013 Jul 26.

15.

Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy.

Burgess DJ, Fu SS, Noorbaloochi S, Clothier BA, Ricards J, Widome R, van Ryn M.

Nicotine Tob Res. 2009 Dec;11(12):1439-47. doi: 10.1093/ntr/ntp158. Epub 2009 Oct 29.

PMID:
19875765
16.

Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.

Hendricks PS, Delucchi KL, Hall SM.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):114-9. doi: 10.1016/j.drugalcdep.2009.12.021. Epub 2010 Jan 21.

17.

Anhedonia, depressed mood, and smoking cessation outcome.

Leventhal AM, Piper ME, Japuntich SJ, Baker TB, Cook JW.

J Consult Clin Psychol. 2014 Feb;82(1):122-9. doi: 10.1037/a0035046. Epub 2013 Nov 11.

18.

Distress tolerance and early smoking lapse.

Brown RA, Lejuez CW, Kahler CW, Strong DR, Zvolensky MJ.

Clin Psychol Rev. 2005 Sep;25(6):713-33. Review.

19.

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB.

Arch Gen Psychiatry. 2009 Nov;66(11):1253-62. doi: 10.1001/archgenpsychiatry.2009.142. Erratum in: Arch Gen Psychiatry. 2010 Jan;67(1):77. Dosage error in article text.

20.

Impulsivity and smoking relapse.

Doran N, Spring B, McChargue D, Pergadia M, Richmond M.

Nicotine Tob Res. 2004 Aug;6(4):641-7.

PMID:
15370160
Items per page

Supplemental Content

Write to the Help Desk